Dark

NKTR
Nektar Therapeutics
stock NASDAQ

Market Open

Jun 11, 2025 9:47:53 AM EDT

10.50USD-7.489%(-0.85)64,394

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 11, 2025 8:50:30 AM EDT

11.35USD0.000%(0.00)3,001

After-hours

Jun 10, 2025 4:56:30 PM EDT

11.08USD-2.679%(-0.31)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

1.96B

CEO

Howard Robin

Headquarters

San Francisco, California, USA

Industry

Biotechnology

Last Split

Jun 9, 20251for15reverse

AMGN RELL AZN NVS BAX JNJ PFE MRK ALKS XLV

NKTR Stats

Avg. Vol. 10 Day

333,374

Avg. Vol. 30 Day

194,946

Employees

509

Market Cap

1,955,948,710

Shares Out.

186,103,588

On/Off Exchange

38%/62%

6 Month Beta

1.55

1 Year Beta

1.58

2 Year Beta

1.79

3 Year Beta

1.69

52 Week Low

6.48

52 Week High

22.79

SMA50

10.00

SMA200

14.52

1 Week

-6.12%

1 Month

-1.98%

3 Month

-14.47%

6 Month

-31.31%

1 Year

-44.39%

2 Year

+23.90%

5 Year

-96.54%

Profile

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

NKTR Stock Summary

Nektar Therapeutics (NASDAQ:NKTR) stock price today is $10.50, and today's volume is 64,394. NKTR is down -7.489% today. The 30 day average volume is 194,946. NKTR market cap is 1.96B with 186,103,588 shares outstanding.

document.getElementById("kHGd6G").onerror = function(){this.style.display='none';}; .dark-mode .TcVSH1{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .TcVSH1{ color: #333333; background-color: white; border: 2px solid #333333; }NKTRNektar Therapeuticsstock NASDAQ

NKTR Stock Summary

NKTR
Nektar Therapeutics
stock NASDAQ